States that although Japan’s pharmaceutical industry has succeeded in steadily advancing its total sales revenues in recent years, its market share of worldwide volume has actually retreated slightly. Its major competitor continues to be the USA, while its three top European rivals: Germany,...

Purpose – This study aims to increase understanding of the factors that affect retail pharmacy performance. This paper investigates how various product-, store-, customer- and competitor characteristics affect over-the-counter (OTC) drug sales and thus store performance....

How do you ensure that representatives can confidently sell a complex product to a sophisticated audience? This was the problem faced by a European pharmaceutical company whose salesforce and managers needed to understand the features and benefits of its novel “high tech” molecule – and be...

Building on a previous study of retail change the impact of the German unification on retail pharmacies is conceptualized in terms of the interaction between changes in system and life world with the retail pharmacist located at the interface between the two realms. A series of key informant...

The present paper compares the protests that CVS, a leading chain retailer, experienced as it attempted to establish a new drug‐store on the Upper West Side of New York City’s borough of Manhattan with those Walgreen, another major chain pharmacy, encountered as it attempted to enter a...

Presents a brief account of the development of antibiotics so as to put such drugs in perspective. Then the issue of antibiotic resistance is considered and Tisdell’s economic analysis of the phenomenon is presented. Emphasis is placed on the inter‐generational trade‐off that is associated...

The rapid proliferation of drugs being switched from prescription (Rx) to over‐the‐counter (OTC) status within the USA has raised a number of important consumer behavior and public policy concerns. The following issue served as the focus of our research. Given the increasing assortment and...

The pharmaceutical industry is characterized by high R&D costs and increasing competition. New pharmaceutical products are often provided patent protection to help companies recoup their R&D costs. The end of this period of market exclusivity is a challenging period for these companies....

Structured like a textbook, the second edition of this referencecovers all aspects of biopharmaceutical manufacturing, includinglegal and regulatory issues, production facility design, andquality assurance, with a focus on supply chain management andregulations in emerging markets and cost...